Learn more about our publications and research
Filter by year:
Drugmakers have had to confront patient distrust of the medical system and the system’s marginalization of sickle cell patients, reports Marketwatch. Read the full article, featuring interview with Modus Therapeutics Chief Executive Ellen Donnelly.
Sankt Eriksgatan 117,
SE-113 43 Stockholm, Sweden
© 2019 Modus Therapeutics. | All Rights Reserved.